In the news · 48h FDA 34 Eli Lilly 17 Roche 10 Johnson & Johnson 7 AstraZeneca 4 Merck & Co. (MSD) 4 Bayer 2 Sanofi 2

Trials & R&D · first seen 1h ago, updated 1h ago

Genentech's Gazyva gains indication for idiopathic nephrotic syndrome

1 outlet Roche

Coverage 1 article · 1 outlet

Seeking Alpha Healthcare 1h ago
Genentech's Gazyva gains indication for idiopathic nephrotic syndrome